Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06358859 · ClinicalTrials.gov registry record · NA

Delta GREENS Food is Medicine Intervention

A NA study of Obesity and Diabetes, sponsored by Tufts University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06358859: Recruiting NA study of Obesity and Diabetes, sponsored by Tufts University.

NCT06358859 is a NA study of Obesity and Diabetes that is actively recruiting participants, run by Tufts University. The registered enrollment target is 300 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06358859, a NA study of Obesity and Diabetes, is actively recruiting participants, sponsored by Tufts University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Though the Mississippi Delta has a rich agricultural history and some of the nation's most fertile soil, residents have experienced the legacy of slavery and economic exploitation through food insecurity and poverty for generations. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta Growing a Resilient, Enriching, Equitable, Nourishing food System (GREENS) Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Primary Outcome

Change in HbA1c in the intervention group compared to the control group

Interventions

  • OTHER Food is Medicine

Study Locations (1)

Massachusetts

  • Tufts University - Boston

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-06-05
Est. Completion 2027-05
Phase NA
Tufts University

163 total trials

What NCT06358859 shows while recruiting

NCT06358859 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (63% lower).

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Food is Medicine is the first listed.

NCT06358859 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06358859 about?

NCT06358859 is a clinical study titled "Delta GREENS Food is Medicine Intervention". Though the Mississippi Delta has a rich agricultural history and some of the nation's most fertile soil, residents have experienced the legacy of slavery and economic exploitation through food insecurity and poverty for generations. This project focuses on Bolivar, Washington, and Sunflower, contigu...

What is the current status of trial NCT06358859?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-06-05. Estimated completion is 2027-05.

What conditions does trial NCT06358859 study?

This clinical trial studies the following conditions: Obesity, Diabetes, High Blood Pressure, Cardiometabolic Risk Factors, Nutrition Security.

What interventions are being tested in trial NCT06358859?

The interventions under investigation include: Food is Medicine (OTHER).

Who is sponsoring clinical trial NCT06358859?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06358859 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06358859's enrollment target sits among peer trials

300 217th of 1053 higher than 825 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06358859, the US trial registry maintained by the National Library of Medicine. NCT06358859 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.